A short course of infusion of a hydrogen sulfide-donor attenuates endotoxemia induced organ injury via stimulation of anti-inflammatory pathways, with no additional protection from prolonged infusion

Cytokine

Volumn 61, Issue 2, 2013, Pages 614-621

  Aslami, Hamid ^a   Beurskens, Charlotte J P ^a   Beer, Friso M de ^a   Kuipers, Maria T ^a   Roelofs, Joris J T H ^a   Hegeman, Maria A ^a   Van der Sluijs, Koen F ^a   Schultz, Marcus J ^a   Juffermans, Nicole P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Acute respiratory distress syndrome; Inflammation; Interleukin 10; Multiple organ failure; Sepsis

Indexed keywords

HYDROGEN SULFIDE; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; SODIUM HYDROSULFIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INFUSION; ENDOTOXEMIA; KIDNEY INJURY; LUNG INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BLOOD GAS ANALYSIS; BODY TEMPERATURE; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; ENDOTOXEMIA; HUMANS; HYDROGEN SULFIDE; INFUSIONS, INTRAVENOUS; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; LUNG; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84873174549     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.11.018     Document Type: Article

References (31)

1. American college of chest physicians/society of critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
2. Dinarello C.A., Gelfand J.A., Wolf S.M. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993, 269:1829-1835.
3. Ranieri V.M., Rubenfeld G.D., Thompson B.T., Ferguson N.D., Caldwell E., Fan E., et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012, 307:2526-2533.
4. Brivet F.G., Kleinknecht D.J., Loirat P., Landais P.J. Acute renal failure in intensive care units-causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study, French study group on acute renal failure. Crit Care Med 1996, 24:192-198.
5. Uchino S., Kellum J.A., Bellomo R., Doig G.S., Morimatsu H., Morgera S., et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818.
6. Sprung C.L., Sakr Y., Vincent J.L., Le Gall J.R., Reinhart K., Ranieri V.M., et al. An evaluation of systemic inflammatory response syndrome signs in the sepsis occurrence in acutely Ill patients (SOAP) study. Intensive Care Med 2006, 32:421-427.
7. Reedy S.J., Schwartz M.D., Morgan B.W. Suicide fads: frequency and characteristics of hydrogen sulfide suicides in the United States. West J Emerg Med 2011, 12:300-304.
8. Wagner F., Asfar P., Calzia E., Radermacher P., Szabo C. Bench-to-bedside review: Hydrogen sulfide-the third gaseous transmitter: applications for critical care. Crit Care 2009, 13:213.
9. Collin M., Anuar F.B., Murch O., Bhatia M., Moore P.K., Thiemermann C. Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br J Pharmacol 2005, 146:498-505.
10. Li L., Bhatia M., Zhu Y.Z., Zhu Y.C., Ramnath R.D., Wang Z.J., et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005, 19:1196-1198.
11. Ganster F., Burban M., de la Bourdonnaye M., Fizanne L., Douay O., Loufrani L., et al. Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats. Crit Care 2010, 14:R165.
12. Li T., Zhao B., Wang C., Wang H., Liu Z., Li W., et al. Regulatory effects of hydrogen sulfide on IL-6, IL-8 and IL-10 levels in the plasma and pulmonary tissue of rats with acute lung injury. Exp Biol Med 2008, 233:1081-1087.
13. Li L., Salto-Tellez M., Tan C.H., Whiteman M., Moore P.K. GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Free Radic Biol Med 2009, 47:103-113.
14. Osipov R.M., Robich M.P., Feng J., Liu Y., Clements R.T., Glazer H.P., et al. Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection. J Cardiovasc Pharmacol 2009, 54:287-297.
15. Hosgood S.A., Nicholson M.L. Hydrogen sulphide ameliorates ischaemia-reperfusion injury in an experimental model of non-heart-beating donor kidney transplantation. Br J Surg 2010, 97:202-209.
16. Chen Y., Liu Z., Xie X. Hydrogen sulphide attenuates renal and cardiac injury after total hepatic ischemia and reperfusion. J Surg Res 2010, 164:e305-e313.
17. Aslami H., Heinen A., Roelofs J.J., Zuurbier C.J., Schultz M.J., Juffermans N.P. Suspended animation inducer hydrogen sulfide is protective in an in vivo model of ventilator-induced lung injury. Intensive Care Med 2010, 36:1946-1952.
18. Renckens R., Roelofs J.J., Florquin S., de Vos A.F., Pater J.M., Lijnen H.R., et al. Endogenous tissue-type plasminogen activator is protective during Escherichia coli-induced abdominal sepsis in mice. J Immunol 2006, 177:1189-1196.
19. Bhatia M. Hydrogen sulfide as a vasodilator. IUBMB Life 2005, 57:603-606.
20. Bos E.M., Leuvenink H.G., Snijder P.M., Kloosterhuis N.J., Hillebrands J.L., Leemans J.C., et al. Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephol 2009, 20:1901-1905.
21. Norman J.G., Fink G.W., Denham W., Yang J., Carter G., Sexton C., et al. Tissue-specific cytokine production during experimental acute pancreatitis. a probable mechanism for distant organ dysfunction. Dig Dis Sci 1997, 42:1783-1788.
22. Zhang H., Zhi L., Moochhala S., Moore P.K., Bhatia M. Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-kappa B. Am J Physiol Lung Cell Mol Physiol 2007, 292:L960-L971.
23. Bracht H., Scheuerle A., Groger M., Hauser B., Matallo J., McCook O., et al. Effects of intravenous sulfide during resuscitated porcine hemorrhagic shock. Crit Care Med 2012, 40:2157-2167.
24. Wolthuis E.K., Vlaar A.P., Choi G., Roelofs J.J., Juffermans N.P., Schultz M.J. Mechanical ventilation using non-injurious ventilation settings causes lung injury in the absence of pre-existing lung injury in healthy mice. Crit Care 2009, 13:R1.
25. Plotz F.B., Slutsky A.S., van Vught A.J., Heijnen C.J. Ventilator-induced lung injury and multiple system organ failure: a critical review of facts and hypotheses. Intensive Care Med 2004, 30:1865-1872.
26. Aslami H., Schultz M.J., Juffermans N.P. Potential applications of hydrogen sulfide-induced suspended animation. Curr Med Chem 2009, 16:1295-1303.
27. Zanardo R.C., Brancaleone V., Distrutti E., Fiorucci S., Cirino G., Wallace J.L. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 2006, 20:2118-2120.
28. Kuhns D.B., Alvord W.G., Gallin J.I. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 1995, 171:145-152.
29. Pan L.L., Liu X.H., Gong Q.H., Wu D., Zhu Y.Z. Hydrogen sulfide attenuated tumor necrosis factor-alpha-induced inflammatory signaling and dysfunction in vascular endothelial cells. PLoS One 2011, 6:e19766.
30. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Eng J Med 2003, 348:138-150.
31. Bone R.C. Sir Isaac Newton, sepsis. SIRS CARS Crit Care Med 1996, 24:1125-1128.